Classified in: HealthSubjects: RCL,
PSF,
CFG
Food Recall Warning (Allergen) - RemarkaBall brand Crunchy Energy Balls recalled due to undeclared milk
OTTAWA, ON, June 30, 2022 /CNW/ - Product photos are available: https://recalls-rappels.canada.ca/en/alert-recall/remarkaball-brand-crunchy-energy-balls-recalled-due-undeclared-milk
Summary
- Brand(s): RemarkaBall
- Product: Crunchy Energy Balls
- Companies: Fitwave
- Issue: Food ? Allergen ? Milk
- Category: Candy, confectionary, snacks and sweeteners
- What to do: Do not consume recalled products to which you are allergic or sensitive
- Audience: General public
- Recall class: Class 1
Affected products
Brand
| Product
| Size
| UPC
| Codes
|
RemarkaBall
| Crunchy Almond Crunchy Energy Balls
| 78 g
| 6 27987 33068 7
| All codes where milk is not declared on the label
|
RemarkaBall
| Crunchy-Hazelnuts Crunchy Energy Balls
| 78 g
| 6 27987 33066 3
| All codes where milk is not declared on the label
|
Issue
The affected products are being recalled from the marketplace because they may contain milk which is not declared on the label.
The recalled products have been sold in Alberta and online.
What you should do
- Check to see if you have recalled products
- Do not consume recalled products to which you are allergic or sensitive as they may cause a serious or life-threatening reaction
- Do not serve, use, sell or distribute recalled products
- Recalled products should be thrown out or returned to the location where they were purchased
Learn more:
Background
This recall was triggered by Canadian Food Inspection Agency test results.
There have been no reported reactions associated with the consumption of these products.
What is being done
The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products.
The CFIA is verifying that industry is removing recalled products from the marketplace.
SOURCE Canadian Food Inspection Agency (CFIA)
These press releases may also interest you
at 21:05 |
|
|
BioDuro-Sundia, an industry-leading drug discovery, development and commercial service CRDMO backed by Advent International, and X-Chem, a DEL technology pioneer in small molecule drug discovery, jointly announced the launch of DNA Encoded Compound...
|
at 20:30 |
|
|
On August 1, 2022, U.S. time, ImmVira's brand new oncolytic herpes simplex virus ("oHSV") product MVR-C5252 targeting Malignant Glioma has obtained Orphan Drug Designation ("ODD") from U.S. Food and Drug Administration ("FDA").
Malignant glioma has...
|
at 20:10 |
|
|
--ASC61 is an in-house developed oral PD-L1 small molecule inhibitor prodrug that showed significant antitumor efficacy in preclinical studies as a single agent in multiple animal models
--ASC61-A treatment induced secretion of IFN? in a...
|
at 20:05 |
|
|
GEMSTONE-301 study result was presented at IASLC 2022 World Conference on Lung Cancer. In addition, the leading Principal Investigator Professor Yi-Long Wu was invited to highlight key data in a press conferenceIn the final progression-free survival...
|
at 20:00 |
|
|
NaoTrac, the CE-certified neurosurgical navigation robot, achieved approval from Taiwan's Food and Drug Administration (TFDA) in July 2022, and is planned for submission to the FDA (U.S. Food and Drug Administration) for clearance by the end of 2022....
|
at 20:00 |
|
|
Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces the appointment of...
|
|
|
|
News published on 1 july 2022 at 00:47 and distributed by: